Preclinical Efficacy and Immunological Safety of FR104, an Antagonist Anti-CD28 Monovalent Fab′ Antibody-Reference-Cited by-同舟云学术

Preclinical Efficacy and Immunological Safety of FR104, an Antagonist Anti-CD28 Monovalent Fab′ Antibody

Published:2012-07-03 Issue:10 Volume:12 Page:2630-2640
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:

Author:

Poirier N.,Mary C.,Dilek N.,Hervouet J.,Minault D.,Blancho G.,Vanhove B.

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-6143.2012.04164.x/fullpdf

Reference67 articles.

1. CTLA-4 control over Foxp3+ regulatory T cell function;Wing;Science,2008

2. Sustained suppression by Foxp3+ regulatory T cells is vital for infectious transplantation tolerance;Kendal;J Exp Med,2011

3. B7/CTLA4 pathway is essential for generating regulatory cells after intratracheal delivery of alloantigen in mice;Akiyama;Transplantation,2002

4. CTLA-4 regulates induction of anergy in vivo;Greenwald;Immunity,2001

5. Acquired thymic tolerance: role of CTLA4 in the initiation and maintenance of tolerance in a clinically relevant autoimmune disease model;Issazadeh;J Immunol,1999

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights and strategies to promote immune tolerance in allogeneic hematopoietic stem cell transplantation recipients;Translational Autoimmunity;2023

2. New immunosuppressive agents in transplantation;La Presse Médicale;2022-12

3. Nouvelles stratégies immunosuppressives en transplantation;Bulletin de l'Académie Nationale de Médecine;2022-04

4. The Role of Co-Signaling Molecules in Psoriasis and Their Implications for Targeted Treatment;Frontiers in Pharmacology;2021-07-20

5. Human amnion-derived mesenchymal stem cells attenuate xenogeneic graft-versus-host disease by preventing T cell activation and proliferation;Scientific Reports;2021-01-28